by Clinical Neuropsychologist | Wednesday, February 19, 2025 | Dementia
Abstract Recent evidence suggests that ocular testing holds promise as a non-invasive and cost-effective method for the early detection of Alzheimer’s disease (AD). After interviews with neurologists, optometrists, primary care physicians, and ophthalmologists,...
by Clinical Neuropsychologist | Wednesday, February 19, 2025 | Dementia
Abstract INTRODUCTION We examined how abnormal prefrontal neurophysiology and changes in gamma-aminobutyric acid-ergic (GABAergic) neurotransmission contribute to behavioral impairments in disorders associated with frontotemporal lobar degeneration (FTLD). METHODS We...
by Clinical Neuropsychologist | Wednesday, February 19, 2025 | Dementia
Abstract INTRODUCTION Early-onset and late-onset Alzheimer’s disease (EOAD and LOAD, respectively) have distinct clinical manifestations, with prior work based on small samples suggesting unique patterns of neurodegeneration. The current study performed a...
by Clinical Neuropsychologist | Wednesday, February 19, 2025 | Dementia
Abstract INTRODUCTION To study the relationship of late-life hemoglobin A1C (A1C) with postmortem neuropathology in older adults with and without diabetes mellitus (DM). METHODS A total of 990 participants from five cohort studies of aging and dementia with at least...
by Clinical Neuropsychologist | Friday, February 14, 2025 | Dementia
Alzheimer’s &Dementia, Volume 21, Issue 2, February 2025. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: Rong Xu | February 14, 2025...
